Form 4: Surgery Partners Executive Jennifer Baldock Acquires Shares Following Performance Vesting

Jennifer Baldock, Chief Admin & Dev Officer of Surgery Partners, acquired 22,209 shares of common stock on January 31, 2025, following the satisfaction of performance vesting criteria.

Summary

• On January 31, 2025, Jennifer Baldock, Chief Admin & Dev Officer of Surgery Partners, acquired 22,209 shares of common stock.
• The acquisition was a result of performance stock unit awards granted on March 11, 2022, that vested based on performance criteria over a three-year period ending December 31, 2024.
• The shares vested immediately upon certification by the Board on January 31, 2025.
• Following the transaction, Baldock directly owns 205,853 shares of Surgery Partners common stock.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as the stock acquisition is a result of meeting performance criteria, suggesting the company is performing well. However, it's a routine transaction and doesn't necessarily indicate a major shift in the company's prospects.

Positives

• The vesting of performance-based stock units suggests that the company met certain performance targets, which is a positive indicator.

Industry Context

Executive stock acquisitions are common in the healthcare industry as part of compensation packages designed to align management interests with shareholder value.

Comparison to Industry Standards

• Executive compensation packages in the healthcare sector often include performance-based equity awards, similar to the stock units granted to Jennifer Baldock.
• Companies like HCA Healthcare and Tenet Healthcare also utilize stock options and restricted stock units as part of their executive compensation plans.

Stakeholder Impact

• The stock acquisition could have a slightly positive impact on shareholders as it aligns management's interests with the company's performance.

Key Dates